91 related articles for article (PubMed ID: 1059888)
1. Prostatic carcinoma. Treated at categorical center, 1960-1969.
Murphy GP; Saroff J; Joiner J; Gaeta J
N Y State J Med; 1975 Sep; 75(10):1663-9. PubMed ID: 1059888
[No Abstract] [Full Text] [Related]
2. Prostatic carcinoma treated at categorical center: clinical and pathologic observations.
Schoonees R; Palma LD; Gaeta JF; Moore RH; Murphy GP
N Y State J Med; 1972 May; 72(9):1021-7. PubMed ID: 4502386
[No Abstract] [Full Text] [Related]
3. Prostatic carcinoma treated at a categorical center, 1970--1979.
Slack NH; Brady MF; Murphy GP
N Y State J Med; 1983 Apr; 83(5):699-705. PubMed ID: 6575275
[No Abstract] [Full Text] [Related]
4. Lymph node involvement in prostatic carcinoma.
Varkarakis MJ; Murphy GP; Nelson CM; Chehval M; Moore RH; Flocks RH
Urol Clin North Am; 1975 Feb; 2(1):197-212. PubMed ID: 1128748
[No Abstract] [Full Text] [Related]
5. [Metastatic prostate carcinoma].
Smith MR; Kantoff P; Talcott J
Praxis (Bern 1994); 2001 Sep; 90(38):1653-8. PubMed ID: 11675919
[No Abstract] [Full Text] [Related]
6. Analysis of factors influencing survival of 109 men with carcinoma of the prostate treated conservatively.
Hand JR
Trans Am Assoc Genitourin Surg; 1973; 65():84-99. PubMed ID: 4763516
[No Abstract] [Full Text] [Related]
7. Natural history and staging of prostate cancer.
Whitmore WF
Urol Clin North Am; 1984 May; 11(2):205-20. PubMed ID: 6375067
[TBL] [Abstract][Full Text] [Related]
8. [The course of prostatic carcinoma].
Meinhardt W; Horenblas S; Newling DW
Ned Tijdschr Geneeskd; 1995 Jun; 139(25):1271-5. PubMed ID: 7609801
[No Abstract] [Full Text] [Related]
9. Current concepts concerning carcinoma of the prostate.
Skinner DG
Surg Annu; 1973; 5():393-406. PubMed ID: 4602222
[No Abstract] [Full Text] [Related]
10. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul P
Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
[No Abstract] [Full Text] [Related]
11. [Carcinoma of the prostate. Occurence, pathological-anatomical diagnosis and prognosis].
Glück E
Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1941-3. PubMed ID: 4767933
[No Abstract] [Full Text] [Related]
12. [The opportunities of the treatment for patients with disseminated prostate gland cancer (the survey of literature)].
Shaplygin LV; Furashov DV; Deviatov AS; Monakov DM; Segedin RE
Voen Med Zh; 2006 Jun; 327(6):39-45. PubMed ID: 16898292
[No Abstract] [Full Text] [Related]
13. [Therapy of advanced prostatic carcinoma: personal experience].
Gatti A; Brunetti A; Petraglia B
Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):79-82. PubMed ID: 1570529
[TBL] [Abstract][Full Text] [Related]
14. Criteria for evaluating patient responses to treatment modalities for prostatic cancer.
Slack NH; Murphy GP
Urol Clin North Am; 1984 May; 11(2):337-42. PubMed ID: 6375069
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
Chisholm GD
Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
[No Abstract] [Full Text] [Related]
16. Leiomyosarcoma of the prostate.
Christoffersen J
Acta Chir Scand Suppl; 1973; 433():75-84. PubMed ID: 4575149
[No Abstract] [Full Text] [Related]
17. [Prostate cancer in Orebro county from 1958-1967].
Dolk T; Fritjofsson A
Lakartidningen; 1974 Sep; 71(38):3517-9. PubMed ID: 4410606
[No Abstract] [Full Text] [Related]
18. Prostatic cancer: the case for surveillance.
Smith PH
Turk J Pediatr; 1984; 26(1-4):267-72. PubMed ID: 6537079
[No Abstract] [Full Text] [Related]
19. Carcinoma of the prostate. Secondary treatment.
Hedlund PO
Scand J Urol Nephrol Suppl; 1991; 139():53-5. PubMed ID: 1767275
[No Abstract] [Full Text] [Related]
20. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
